Clinical Trial Update: Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of posaconazole tablets in participants at high risk for invasive fungal infections, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infections | Phase 1 | Status: COMPLETED | Results posted: 2013-03-28